Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftazidime and Cloxacillin for prevention of hemodialysis tunneled catheter-related bloodstream infection
IRCT2017060212789N15Phase 3Completed
- Sponsor
- Vice Chancellor for Research of Kurdistan University of Medical Sciences
- Start
- Sep 2016
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ceftazidime and cloxacillin in catheter-associated bloodstream infection (CRBSI) and bacterial disease, sponsored by Vice Chancellor for Research of Kurdistan University of Medical Sciences. Started Sep 2016; status: completed.
02
Drugs
ceftazidimecloxacillin
03
Conditions
catheter-associated bloodstream infection (CRBSI)bacterial disease
Beyond the preview
Go deeper on IRCT2017060212789N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017060212789N15.